Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Hepatitis B | Correction

Correction to: Using a hepatitis B surveillance system evaluation in Fujian, Hainan, and Gansu provinces to improve data quality and assess program effectiveness, China, 2015

Authors: Hui Zheng, Alexander J. Millman, Jeanette J. Rainey, Fuzhen Wang, Rui Zhang, Hong Chen, Zundong Yin, Huaqing Wang, Guomin Zhang

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Excerpt

Correction to: BMC Infect Dis 20, 547 (2020)
Metadata
Title
Correction to: Using a hepatitis B surveillance system evaluation in Fujian, Hainan, and Gansu provinces to improve data quality and assess program effectiveness, China, 2015
Authors
Hui Zheng
Alexander J. Millman
Jeanette J. Rainey
Fuzhen Wang
Rui Zhang
Hong Chen
Zundong Yin
Huaqing Wang
Guomin Zhang
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Hepatitis B
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05708-x

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine